BCL2 and diffuse large B-cell lymphoma: MYC rearrangements have been reported in roughly 10% of cases with DLBCL morphology, of which 40% were DLBCL/HGBL-MYC/BCL2 and 10–15% DLBCL/HGBL-MYC/BCL2 with additional BCL6 rearrangements [18,39].